Treatment accepted for restricted use within NHS Scotland.
Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures
Monitor serum phosphate levels in patients treated with multiple high-dose administrations, or those on long-term treatment, and in those with pre-existing risk factors for hypophosphataemia.
SMC accepts treatments for hyperkalaemia, reversal of anticoagulation and acquired thrombotic thrombocytopenic purpura
Author: Saffron Reavley, general practitioner, Bristol.
Author: Laura Toma, general practitioner, Kent. Reviewed by Louise Newson, general practitioner, Birmingham.